Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
No confirmed Retatrutide FDA approval date has been announced publicly
Key findings at the highest dose (12mg weekly): Up to 24% mean body weight reduction over 48 weeks Significant reductions in fasting glucose and insulin resistance markers Meaningful reductions in liver fat content, relevant for participants with metabolic-associated fatty liver disease Once-weekly subcutaneous dosing was generally well-tolerated For context, semaglutide at its approved dose achieves approximately 1517% body weight reduction over 68 weeks
Current expectations point to FDA review and potential approval in the 2027 to 2028 range
Il est galement conseill de consulter votre mdecin avant de le prendre, en particulier si vous avez des problmes de sant existants, si vous tes enceinte, si vous allaitez ou si vous prenez d'autres mdicaments
US$ 27.24
US$ 20.98
US$ 27.53
